Chiesi USA Inc (CRTX:US)
was acquired by 97612Z:IM
Cahiesi USA, Inc. operates as a specialty pharmaceutical company. The Company develops products that are designed to regulate the body's inflammatory response associated with asthma and critical care diseases, and products for the respiratory market. Chiesi serves the hospital and adjacent specialty markets in the United States.